Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Terminated1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT01533948Phase 2Terminated
Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by Surgery
Extraocular Extension MelanomaMetastatic Intraocular MelanomaRecurrent Intraocular Melanoma+9 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jeffrey Weber

University of Southern California

Moderately Similar
4 trials

Shared therapeutic areas:

Stage IV MelanomaExtraocular Extension MelanomaRecurrent Melanoma+9 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Frank Hodi

Dana-Farber Cancer Institute

Related
2 trials

Shared therapeutic areas:

Stage IV MelanomaRecurrent MelanomaStage IIIB Melanoma+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

John P. Fruehauf, MD, PhD

Chao Family Comprehensive Cancer Center

Related
2 trials

Shared therapeutic areas:

Stage IIIA MelanomaStage IIIB MelanomaStage IIIC Melanoma
Similarity Score8%

Takami Sato, MD

Thomas Jefferson University

Related
2 trials

Shared therapeutic areas:

Stage IIIA Intraocular MelanomaStage IIIB Intraocular MelanomaStage IIIC Intraocular Melanoma
Similarity Score8%

Sapna Patel

M.D. Anderson Cancer Center

Related
2 trials

Shared therapeutic areas:

Metastatic Intraocular MelanomaRecurrent Intraocular MelanomaStage IV Intraocular Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Wenyin Shi, MD, PhD

Thomas Jefferson University

Related
5 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV Melanoma
Similarity Score5%

Evanthia Galanis

Mayo Clinic

Related
2 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Cassian Yee

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
3 trials

Shared therapeutic areas:

Stage IV MelanomaRecurrent Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

David Solit

Memorial Sloan Kettering Cancer Center

Related
2 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Kevin Kim

M.D. Anderson Cancer Center

Related
3 trials

Shared therapeutic areas:

Stage IV MelanomaRecurrent Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01533948Phase 2PrincipalInvestigator

Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by Surgery

Extraocular Extension MelanomaMetastatic Intraocular MelanomaRecurrent Intraocular Melanoma+9 more
Terminated

All 1 trials loaded